Gedea Biotech
Gedea Biotech develops pHyph to treat and prevent the recurrence of bacterial vaginosis
Lund, Swedengedeabiotech.com ↗
Total raised
€1.3M
€1,300,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-25 | Other | €1.3M | Angel Investors,Private Investors | View deal → |